High CD163 expression was associated with invasion depth (p = 0.037), lymph node metastasis (p = 0.021), distant metastasis (p = 0.007) and TNM stage of patients (p = 0.003; Table 1). This evidence concerns the gene CD163 and metastatic malignant neoplasm in the lymph nodes.